Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05861531 · ClinicalTrials.gov registry record · NA
Combined Oral Motor Stimulation and Language on Preterm Infant Feeding
A NA study of Maternal Behavior and Language Development, sponsored by Women and Infants Hospital of Rhode Island.
- Recruiting
- Registry status
- NA
- Development phase
- 124
- Enrollment target
- 1
- Study location
NCT05861531: Recruiting NA study of Maternal Behavior and Language Development, sponsored by Women and Infants Hospital of Rhode Island.
NCT05861531 is a NA study of Maternal Behavior and Language Development that is actively recruiting participants, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 124 participants, below the 580-participant average among 13 other Maternal Behavior trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05861531, a NA study of Maternal Behavior and Language Development, is actively recruiting participants, sponsored by Women and Infants Hospital of Rhode Island.
- RECRUITING
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled trial to study an oromotor stimulation in combination with a reading curriculum in the NICU among preterm infants using oral muscle exercises, Language Environment Analysis (LENA) recordings, linguistic feedback, and a language curriculum to improve the neonatal inpatient oral feeding and language outcomes for preterm infants.
Primary Outcome
Days to first oral feeding, days to complete oral feeding, hospital days
Conditions Studied
Interventions
- BEHAVIORAL Oromotor stimulation
- BEHAVIORAL Reading curriculum
- BEHAVIORAL LENA recording
- BEHAVIORAL LENA linguistic feedback
- BEHAVIORAL No oromotor stimulation
Study Locations (1)
Rhode Island
- Women & Infants NICU - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2030-07-01 |
| Phase | NA |
What NCT05861531 shows while recruiting
NCT05861531 is an interventional study that assigns participants to a tested intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap, below the 580-participant average among 13 other Maternal Behavior trials with a reported enrollment target (79% lower).
The record links to 5 conditions, with Maternal Behavior appearing as the primary indexed condition, and to 5 interventions - of which Oromotor stimulation is the first listed.
NCT05861531 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05861531 about?
NCT05861531 is a clinical study titled "Combined Oral Motor Stimulation and Language on Preterm Infant Feeding". This is a randomized controlled trial to study an oromotor stimulation in combination with a reading curriculum in the NICU among preterm infants using oral muscle exercises, Language Environment Analysis (LENA) recordings, linguistic feedback, and a language curriculum to improve the neonatal inpat...
What is the current status of trial NCT05861531?
This trial is currently recruiting. It is a NA study. The enrollment target is 124 participants. The study started on 2025-07-01. Estimated completion is 2030-07-01.
What conditions does trial NCT05861531 study?
This clinical trial studies the following conditions: Maternal Behavior, Language Development, Mother-Infant Interaction, Feeding; Difficult, Newborn, Language Delay.
What interventions are being tested in trial NCT05861531?
The interventions under investigation include: Oromotor stimulation (BEHAVIORAL), Reading curriculum (BEHAVIORAL), LENA recording (BEHAVIORAL), LENA linguistic feedback (BEHAVIORAL), No oromotor stimulation (BEHAVIORAL).
Who is sponsoring clinical trial NCT05861531?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05861531 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Maternal Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05861531's enrollment target sits among peer trials
124 7th of 13 higher than 7 of 13 other Maternal Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Maternal Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mississippi Delta Community Care Home Visits Program
RECRUITING · NA
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Conscious Pregnancy: Supporting Maternal Cardiometabolic Health With Mindfulness
RECRUITING · NA
-
Improving Maternal Sleep and Mental Health
RECRUITING · NA
-
An Intervention to Enhance Well-Being in Trauma Exposed New Mothers
ACTIVE NOT RECRUITING · NA
-
Nurse-Family Partnership Impact Evaluation in South Carolina
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI